Quality assessment of clinical guidelines on probiotics therapy in children with IBD using the AGREE II instrument
- PMID: 33768598
- DOI: 10.1111/jcpt.13422
Quality assessment of clinical guidelines on probiotics therapy in children with IBD using the AGREE II instrument
Abstract
What is known and objective: The morbidity of inflammatory bowel disease (IBD) in children has significantly increased in recent years. The diagnosis and treatment of IBD in children are progressing rapidly. Probiotics have been extensively studied in a variety of gastrointestinal diseases. However, the effectiveness of probiotics for IBD is inconsistent. This study summarized the recommendations on using probiotics from high-quality guidelines, and the recommendations may assist clinicians in the treatment of paediatric IBD.
Methods: Guidelines were identified by searching PubMed, EMBASE, three Chinese literature databases and websites of relevant institutions. Guidelines that addressed the treatments of paediatric IBD in Chinese and English were included and evaluated with the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument to assess methodological quality. The levels of recommendation were also evaluated, and finally, the recommendations of probiotics application in IBD were summarized.
Results and discussion: A total of 14 guidelines that met inclusion criteria were identified and evaluated, and 12 of them were evidence-based (EB) guidelines, and the other two guidelines were developed by consensus. The mean percentages for the AGREE II domain scores were as follows: "Scope and purpose" 97.22%, "Clarity of presentation" 93.78%, "Applicability" 55.85%, "Editorial independence" 59.92%, "Stakeholder involvement" 74.34%, and "Rigor of development" 71.58%. Three guidelines received the Grade A-"Strongly recommended," the rest of the guidelines received a B grade-"Recommended with modifications" in the overall assessment.
What is new and conclusion: The overall quality of the guidelines on IBD management in children was high. Conversely, the fundamental recommendations on the application of probiotics in the treatment of IBD varied. For instance, the recommendations of probiotics on Crohn's disease (CD) were not available by any of the analysed guidelines, the recommendations of utilizing probiotics in treating ulcerative colitis (UC) were not uniform as several guidelines considered using VSL#3 or Escherichia coli Nissle 1917 for the treatment.
Keywords: AGREE II instrument; Crohn's disease (CD); children with IBD; clinical practice guidelines; inflammatory bowel disease (IBD); probiotics; quality assessment; ulcerative colitis (UC).
© 2021 John Wiley & Sons Ltd.
Similar articles
-
Quality assessment of Clinical Practice Guidelines (CPG) for the diagnosis and treatment of inflammatory bowel disease using the AGREE II instrument: a systematic review.BMC Gastroenterol. 2022 Nov 5;22(1):447. doi: 10.1186/s12876-022-02539-9. BMC Gastroenterol. 2022. PMID: 36335292 Free PMC article.
-
Evaluation of pharmacotherapy recommendations in guidelines for inflammatory bowel disease.J Clin Pharm Ther. 2021 Jun;46(3):599-609. doi: 10.1111/jcpt.13368. Epub 2021 Feb 5. J Clin Pharm Ther. 2021. PMID: 33543814
-
Complementary and alternative medicine mention and recommendations in inflammatory bowel disease guidelines: systematic review and assessment using AGREE II.BMC Complement Med Ther. 2023 Jul 11;23(1):230. doi: 10.1186/s12906-023-04062-0. BMC Complement Med Ther. 2023. PMID: 37434218 Free PMC article.
-
Methodological Quality Assessment of Meta-Analyses and Systematic Reviews of Probiotics in Inflammatory Bowel Disease and Pouchitis.PLoS One. 2016 Dec 22;11(12):e0168785. doi: 10.1371/journal.pone.0168785. eCollection 2016. PLoS One. 2016. PMID: 28005973 Free PMC article. Review.
-
Quality of therapeutic drug monitoring guidelines is suboptimal: an evaluation using the Appraisal of Guidelines for Research and Evaluation II instrument.J Clin Epidemiol. 2020 Apr;120:47-58. doi: 10.1016/j.jclinepi.2019.10.007. Epub 2019 Oct 31. J Clin Epidemiol. 2020. PMID: 31678686
Cited by
-
The influence of the gut microbiota on B cells in autoimmune diseases.Mol Med. 2025 Apr 22;31(1):149. doi: 10.1186/s10020-025-01195-5. Mol Med. 2025. PMID: 40264032 Free PMC article. Review.
-
Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022.Front Microbiol. 2023 Jul 6;14:1211271. doi: 10.3389/fmicb.2023.1211271. eCollection 2023. Front Microbiol. 2023. PMID: 37485519 Free PMC article. Review.
-
Quality assessment of Clinical Practice Guidelines (CPG) for the diagnosis and treatment of inflammatory bowel disease using the AGREE II instrument: a systematic review.BMC Gastroenterol. 2022 Nov 5;22(1):447. doi: 10.1186/s12876-022-02539-9. BMC Gastroenterol. 2022. PMID: 36335292 Free PMC article.
-
Evaluating the anti-inflammatory and antioxidant efficacy of complementary and alternative medicines (CAM) used for management of inflammatory bowel disease: a comprehensive review.Redox Rep. 2025 Dec;30(1):2471737. doi: 10.1080/13510002.2025.2471737. Epub 2025 Mar 8. Redox Rep. 2025. PMID: 40056427 Free PMC article. Review.
References
REFERENCES
-
- Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011;17(1):423-439.
-
- Ghione S, Sarter H, Fumery M, et al. Dramatic increase in incidence of ulcerative colitis and Crohn's disease (1988-2011): a population-based study of French adolescents. Am J Gastroenterol. 2018;113(2):265-272.
-
- Benchimol EI, Bernstein CN, Bitton A, et al. Trends in epidemiology of pediatric inflammatory bowel disease in Canada: distributed network analysis of multiple population-based provincial health administrative databases. Am J Gastroenterol. 2017;112(7):1120-1134.
-
- Wang XQ, Zhang Y, Xu CD, et al. Inflammatory bowel disease in Chinese children: a multicenter analysis over a decade from Shanghai. Inflamm Bowel Dis. 2013;19(2):423-428.
-
- Wilkins T, Sequoia J. Probiotics for gastrointestinal conditions: a summary of the evidence. Am Fam Physician. 2017;96(3):170-178.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous